nach oben

Cancer Chemotherapy and Pharmacology

Erschienen in:

01.11.2019 | Original Article

Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia

verfasst von: Hui Li, Qiong Xu, Yang Wang, Kailan Chen, Jianxin Li

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The present study was aimed at assessing the value of serum NGAL in identifying early acute kidney injury induced by HDMTX.

Methods

Children aged 1–14 years with newly diagnosed ALL receiving MTX over 3 g/m² were enrolled. Serum NGAL concentrations, serum creatinine (Scr) and MTX concentrations were measured. The area under the receiver-operating characteristic curve (ROC) was used for evaluating variables’ ability of early diagnosis of AKI.

Results

A total of 196 courses of 62 patients were assessed, and 22 courses (11.2%) developed AKI. Twenty-four hours serum NGAL concentrations, 24 h Scr ratio, 48 h Scr ratio, C_MTX24 h, C_MTX48 h, C_MTX72 h were significantly higher in patients with AKI. The combination of 24 h Scr ratio and 24 h serum NGAL had higher value for detecting HDMTX induced AKI compared with the 24 h Scr ratio. And the combination had similar value for detecting HDMTX induced AKI compared with the 48 h Scr ratio. After 48 h, C_MTX48 h had a satisfying accuracy in predicting AKI. The proportion of post-HDMTX sepsis in patients with AKI was significantly higher than that in patients without AKI.

Conclusions

Serum NGAL levels could be used as a marker in identifying the direct kidney tubular damage induced by HDMTX. The combination of 24 h Scr ratio and 24 h serum NGAL had higher value for early diagnosis of HDMTX associated AKI compared with the 24 h Scr ratio.

Borsi JD, Moe PJ (1987) Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children. Cancer 60(12):3020–3024CrossRefPubMed

Murry DJ, Synold TW, Pui CH, Rodman JH (1995) Renal function and methotrexate clearance in children with newly diagnosed leukemia. Pharmacotherapy 15(2):144–149PubMed

Perazella MA (1999) Crystal-induced acute renal failure. Am J Med 106(4):459–465CrossRefPubMed

Christensen ML, Rivera GK, Crom WR, Hancock ML, Evans WE (1988) Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia. J Clin Oncol 6(5):797–801. https://doi.org/10.1200/JCO.1988.6.5.797 CrossRefPubMed

Karremann M, Sauerbier J, Meier C, Vetter C, Schneider H, Buchholz B, Mildenberger S, Durken M (2014) The impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patients. Leuk Lymphoma 55(12):2874–2878. https://doi.org/10.3109/10428194.2014.898143 CrossRefPubMed

Perazella MA, Moeckel GW (2010) Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy. Semin Nephrol 30(6):570–581. https://doi.org/10.1016/j.semnephrol.2010.09.005 CrossRefPubMed

Rask C, Albertioni F, Bentzen SM, Schroeder H, Peterson C (1998) Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia: a logistic regression analysis. Acta Oncol 37(3):277–284CrossRefPubMed

Filler G, Lee M (2018) Educational review: measurement of GFR in special populations. Pediatr Nephrol 33(11):2037–2046. https://doi.org/10.1007/s00467-017-3852-8 CrossRefPubMed

Bosch JP (1995) Renal reserve: a functional view of glomerular filtration rate. Semin Nephrol 15(5):381–385PubMed

10.

Herrera J, Rodriguez-Iturbe B (1998) Stimulation of tubular secretion of creatinine in health and in conditions associated with reduced nephron mass. Evidence for a tubular functional reserve. Nephrol Dial Transpl 13(3):623–629. https://doi.org/10.1093/ndt/13.3.623 CrossRef

11.

Coca SG, Yalavarthy R, Concato J, Parikh CR (2008) Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73(9):1008–1016. https://doi.org/10.1038/sj.ki.5002729 CrossRefPubMed

12.

Malhotra R, Siew ED (2017) Biomarkers for the early detection and prognosis of acute kidney injury. Clin J Am Soc Nephrol 12(1):149–173. https://doi.org/10.2215/CJN.01300216 CrossRefPubMed

13.

Parikh CR, Devarajan P (2008) New biomarkers of acute kidney injury. Crit Care Med 36(4 Suppl):S159–S165. https://doi.org/10.1097/CCM.0b013e318168c652 CrossRefPubMed

14.

Zhang A, Cai Y, Wang PF, Qu JN, Luo ZC, Chen XD, Huang B, Liu Y, Huang WQ, Wu J, Yin YH (2016) Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis. Crit Care 20:41. https://doi.org/10.1186/s13054-016-1212-x CrossRefPubMedPubMedCentral

15.

Matsa R, Ashley E, Sharma V, Walden AP, Keating L (2014) Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients. Crit Care 18(4):R137. https://doi.org/10.1186/cc13958 CrossRefPubMedPubMedCentral

16.

Tong J, Li H, Zhang H, Luo Z, Huang Y, Huang J, He F, Fu J (2015) Neutrophil gelatinase-associated lipocalin in the prediction of contrast-induced nephropathy: a systemic review and meta-analysis. J Cardiovasc Pharmacol 66(3):239–245. https://doi.org/10.1097/FJC.0000000000000268 CrossRefPubMed

17.

Zhou F, Luo Q, Wang L, Han L (2016) Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis. Eur J Cardiothorac Surg 49(3):746–755. https://doi.org/10.1093/ejcts/ezv199 CrossRefPubMed

18.

Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Swaminathan M, Garg AX, Consortium T-A (2011) Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 22(9):1748–1757. https://doi.org/10.1681/asn.2010121302 CrossRefPubMedPubMedCentral

19.

de Miguel D, Garcia-Suarez J, Martin Y, Gil-Fernandez JJ, Burgaleta C (2008) Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs. Nephrol Dial Transpl 23(12):3762–3766. https://doi.org/10.1093/ndt/gfn503 CrossRef

20.

Leveque D, Santucci R, Gourieux B, Herbrecht R (2011) Pharmacokinetic drug-drug interactions with methotrexate in oncology. Expert Rev Clin Pharmacol 4(6):743–750. https://doi.org/10.1586/ecp.11.57 CrossRefPubMed

21.

Wu M, Li Z (2014) Understanding the guidelines for the diagnosis and treatment of childhood acute lymphoblastic leukemia. Zhonghua Er Ke Za Zhi 52(9):645–648PubMed

22.

Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, Herzog CA, Joannidis M, Kribben A, Levey AS, MacLeod AM (2012) Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2(1):1–138. https://doi.org/10.1038/kisup.2012.1 CrossRef

23.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801–810. https://doi.org/10.1001/jama.2016.0287 CrossRefPubMedPubMedCentral

24.

Zhang HN, He XL, Wang C, Wang Y, Chen YJ, Li JX, Niu CH, Gao P (2014) Impact of SLCO1B1 521T > C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate. Pediatr Blood Cancer 61(12):2203–2207. https://doi.org/10.1002/pbc.25191 CrossRefPubMed

25.

Ramsey LB, Balis FM, O’Brien MM, Schmiegelow K, Pauley JL, Bleyer A, Widemann BC, Askenazi D, Bergeron S, Shirali A, Schwartz S, Vinks AA, Heldrup J (2018) Consensus guideline for use of glucarpidase in patients with high-dose methotrexate induced acute kidney injury and delayed methotrexate clearance. Oncologist 23(1):52–61. https://doi.org/10.1634/theoncologist.2017-0243 CrossRefPubMed

26.

Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, Group NM-aI (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54(6):1012–1024. https://doi.org/10.1053/j.ajkd.2009.07.020 CrossRefPubMed

27.

Shemin D, Dworkin LD (2011) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury. Crit Care Clin 27(2):379–389. https://doi.org/10.1016/j.ccc.2010.12.003 CrossRefPubMed

28.

Moledina DG, Hall IE, Thiessen-Philbrook H, Reese PP, Weng FL, Schroppel B, Doshi MD, Wilson FP, Coca SG, Parikh CR (2017) Performance of serum creatinine and kidney injury biomarkers for diagnosing histologic acute tubular injury. Am J Kidney Dis 70(6):807–816. https://doi.org/10.1053/j.ajkd.2017.06.031 CrossRefPubMedPubMedCentral

29.

Aquerreta I, Aldaz A, Giraldez J, Sierrasesumaga L (2002) Pharmacodynamics of high-dose methotrexate in pediatric patients. Ann Pharmacother 36(9):1344–1350. https://doi.org/10.1345/aph.1A446 CrossRefPubMed

30.

Cheng D-H, Lu H, Liu T-T, Zou X-Q, Pang H-M (2018) Identification of risk factors in high-dose methotrexate-induced acute kidney injury in childhood acute lymphoblastic leukemia. Chemotherapy 63(2):100–106. https://doi.org/10.1159/000486823 CrossRef

31.

Vanmassenhove J, Glorieux G, Lameire N, Hoste E, Dhondt A, Vanholder R, Van Biesen W (2015) Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis. BMC Nephrol 16:18. https://doi.org/10.1186/s12882-015-0003-y CrossRefPubMedPubMedCentral

32.

Murugan R, Karajala-Subramanyam V, Lee M, Yende S, Kong L, Carter M, Angus DC, Kellum JA, Genetic, Inflammatory Markers of Sepsis I (2010) Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 77(6):527–535. https://doi.org/10.1038/ki.2009.502 CrossRefPubMed

33.

Ylinen E, Jahnukainen K, Saarinen-Pihkala UM, Jahnukainen T (2014) Assessment of renal function during high-dose methotrexate treatment in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 61(12):2199–2202. https://doi.org/10.1002/pbc.25137 CrossRefPubMed

34.

Reiss SN, Buie LW, Adel N, Goldman DA, Devlin SM, Douer D (2016) Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia. Ann Hematol 95(12):2009–2015. https://doi.org/10.1007/s00277-016-2795-7 CrossRefPubMedPubMedCentral

35.

Lippi G, Meschi T, Nouvenne A, Mattiuzzi C, Borghi L (2014) Neutrophil gelatinase-associated lipocalin in cancer. Adv Clin Chem. https://doi.org/10.1016/b978-0-12-800263-6.00004-5 CrossRefPubMed

36.

Wheeler DS, Devarajan P, Ma Q, Harmon K, Monaco M, Cvijanovich N, Wong HR (2008) Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 36(4):1297–1303. https://doi.org/10.1097/CCM.0b013e318169245a CrossRefPubMedPubMedCentral

Titel: Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia
verfasst von: Hui Li
Qiong Xu
Yang Wang
Kailan Chen
Jianxin Li
Publikationsdatum: 01.11.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Cancer Chemotherapy and Pharmacology / Ausgabe 1/2020
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI: https://doi.org/10.1007/s00280-019-03980-6

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Dose-finding study of modified FLOT (mFLOT) regimen as first-line treatment in Chinese patients with metastatic adenocarcinoma of stomach

Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation

PLX038: a PEGylated prodrug of SN-38 independent of UGT1A1 activity

Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy

Acknowledgement of reviewers 2019

Ganciclovir reduces irinotecan-induced intestinal toxicity by inhibiting NLRP3 activation

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie